Literature DB >> 8208885

Lack of cognitive recovery following withdrawal from long-term benzodiazepine use.

P R Tata1, J Rollings, M Collins, A Pickering, R R Jacobson.   

Abstract

Twenty-one patients with significant long-term therapeutic benzodiazepine (BZ) use, who remained abstinent at 6 months follow-up after successfully completing a standardized inpatient BZ withdrawal regime, and 21 normal controls matched for age and IQ but not for anxiety, were repeatedly tested on a simple battery of routine psychometric tests of cognitive function, pre- and post-withdrawal and at 6 months follow-up. The results demonstrated significant impairment in patients in verbal learning and memory, psychomotor, visuo-motor and visuo-conceptual abilities, compared with controls, at all three time points. Despite practice effects, no evidence of immediate recovery of cognitive function following BZ withdrawal was found. Modest recovery of certain deficits emerged at 6 months follow-up in the BZ group, but this remained significantly below the equivalent control performance. The implications of persisting cognitive deficits after withdrawal from long-term BZ use are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208885     DOI: 10.1017/s0033291700026969

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

1.  Z-drugs.

Authors:  Stephen McCabe
Journal:  Br J Gen Pract       Date:  2007-03       Impact factor: 5.386

Review 2.  Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Authors:  S L Gray; K V Lai; E B Larson
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 3.  Polysomnographic effects of hypnotic drugs. A review.

Authors:  L Parrino; M G Terzano
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

4.  Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research.

Authors:  H Habraken; K Soenen; L Blondeel; J Van Elsen; J Bourda; E Coppens; M Willeput
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

5.  Tapering off benzodiazepines in long-term users: an economic evaluation.

Authors:  Richard C Oude Voshaar; Paul F M Krabbe; Wim J M J Gorgels; Eddy M M Adang; Anton J L M van Balkom; Eloy H van de Lisdonk; Frans G Zitman
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use.

Authors:  Bethea A Kleykamp; Roland R Griffiths; Una D McCann; Michael T Smith; Miriam Z Mintzer
Journal:  Exp Clin Psychopharmacol       Date:  2011-09-19       Impact factor: 3.157

7.  Cognitive effects of long-term benzodiazepine use: a meta-analysis.

Authors:  Melinda J Barker; Kenneth M Greenwood; Martin Jackson; Simon F Crowe
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

8.  Differences in health status between long-term and short-term benzodiazepine users.

Authors:  S M Zandstra; J W Furer; E H van de Lisdonk; J H J Bor; F G Zitman; C van Weel
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

Review 9.  Medication withdrawal trials in people aged 65 years and older: a systematic review.

Authors:  Shoba Iyer; Vasi Naganathan; Andrew J McLachlan; David G Le Couteur
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Benzodiazepines and semantic memory: effects of lorazepam on the Moses illusion.

Authors:  Marie Izaute; Laurence Paire-Ficout; Elisabeth Bacon
Journal:  Psychopharmacology (Berl)       Date:  2003-11-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.